Equities

ICU Medical Inc

ICU Medical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)167.81
  • Today's Change-0.65 / -0.39%
  • Shares traded241.51k
  • 1 Year change+97.47%
  • Beta0.6367
Data delayed at least 15 minutes, as of Nov 25 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.

  • Revenue in USD (TTM)2.34bn
  • Net income in USD-111.01m
  • Incorporated1992
  • Employees14.00k
  • Location
    ICU Medical Inc951 Calle AmanecerSAN CLEMENTE 92673United StatesUSA
  • Phone+1 (949) 366-2183
  • Fax+1 (949) 366-8368
  • Websitehttps://www.icumed.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
LeMaitre Vascular Inc213.03m41.32m2.43bn614.0059.227.3347.6411.401.821.829.4114.730.59921.117.59346,952.8011.629.0212.669.9368.3465.8319.4015.455.52--0.0040.4119.6912.8845.895.9618.9315.51
TransMedics Group Inc401.09m32.64m2.55bn584.0080.9912.1650.596.360.93890.938911.606.250.54393.565.32686,797.904.43-16.084.78-17.9559.3465.378.14-40.477.33--0.7078--158.5379.3630.92--225.12--
Enovis Corp2.00bn-121.38m2.61bn6.55k--0.782917.831.30-2.21-2.1736.4359.610.40231.595.91305,598.20-2.43-0.3569-2.66-0.4156.9648.19-6.03-1.061.120.98890.2876--9.22-4.89-40.29--11.91--
Quidelortho Corp2.82bn-1.87bn2.70bn7.10k--0.8465--0.9581-27.89-27.8942.0447.420.36742.627.84396,859.20-24.3411.34-27.7512.9147.6262.71-66.2520.930.81340.74190.44460.00-8.2141.83-101.84--45.87--
Warby Parker Inc742.53m-32.56m2.78bn2.14k--8.25245.173.75-0.2731-0.27316.202.801.225.70818.21346,975.20-5.37---6.78--55.3257.49-4.39-14.532.06--0.00--11.9819.6742.75------
LivaNova PLC1.24bn23.68m2.79bn2.90k120.492.1341.072.240.42590.425922.8124.130.51192.476.42428,185.900.9777-6.011.12-7.4267.7866.991.91-13.562.872.460.3234--12.890.8278120.34---1.64--
Inari Medical Inc574.50m-78.58m2.91bn1.30k--6.67--5.06-1.35-1.359.907.440.92211.597.46441,921.50-12.61-0.5941-15.24-0.669686.8289.06-13.68-0.62951.40--0.00--28.73135.4094.41--52.46--
Neogen Corp912.20m-23.53m3.25bn2.92k--1.0434.443.56-0.1086-0.10864.2114.470.20132.715.98312,718.20-0.51931.38-0.53461.4449.5648.23-2.584.312.791.030.22150.0012.3717.4158.81--50.02--
Envista Holdings Corp2.50bn-1.34bn3.70bn12.80k--1.20--1.48-7.77-7.7714.5117.860.41064.216.19195,570.30-21.931.94-25.272.3454.2057.65-53.425.291.773.130.31630.00-0.1012-2.04-142.10---4.22--
DENTSPLY SIRONA Inc3.90bn-413.00m3.73bn15.00k--1.50--0.9567-2.07-2.0718.9112.530.56412.945.91260,000.00-5.93-1.14-7.41-1.3252.1853.65-10.51-2.510.84443.210.471--1.10-0.107186.11---4.549.86
Guardant Health Inc692.26m-512.41m4.03bn1.78k------5.83-4.24-4.245.70-0.4880.4153.687.81389,126.50-30.72-22.26-35.19-24.5960.3164.62-74.02-97.075.85-8.041.06--25.4544.1426.76--0.2786--
ICU Medical Inc2.34bn-111.01m4.11bn14.00k--2.0136.121.76-4.57-4.5796.3183.760.53912.1613.94167,149.80-2.561.46-2.901.6532.8734.11-4.742.231.030.51580.43820.00-0.915410.0460.08---1.45--
Haemonetics Corporation1.36bn123.81m4.30bn3.66k35.534.9018.413.162.412.4126.4817.440.60011.877.02372,224.005.465.026.196.0754.0251.749.108.112.0927.430.58230.0012.016.231.8716.40-11.04--
Integer Holdings Corp1.68bn114.44m4.63bn10.50k42.582.8620.932.763.243.2247.8748.330.55944.935.14160,023.803.813.284.103.5327.0626.946.816.402.094.110.40280.0016.035.6238.719.3321.71--
Procept Biorobotics Corp199.84m-100.06m5.06bn626.00--20.23--25.32-1.95-1.953.894.630.50261.833.86319,238.00-25.16---28.58--57.39---50.07--5.07--0.1758--81.55---21.51------
Inspire Medical Systems Inc755.59m33.05m5.66bn1.01k173.448.12148.827.491.091.0925.1523.251.052.469.37747,372.904.60-11.275.12-12.6084.7784.474.37-13.576.94--0.00--53.1965.3252.87--148.37--
Data as of Nov 25 2024. Currency figures normalised to ICU Medical Inc's reporting currency: US Dollar USD

Institutional shareholders

56.09%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Sep 20243.35m13.71%
The Vanguard Group, Inc.as of 30 Sep 20242.62m10.74%
Janus Henderson Investors US LLCas of 30 Sep 20242.40m9.83%
Fuller & Thaler Asset Management, Inc.as of 30 Sep 20241.41m5.78%
SSgA Funds Management, Inc.as of 30 Sep 2024907.61k3.72%
Citadel Advisors LLCas of 30 Sep 2024653.34k2.68%
Columbia Management Investment Advisers LLCas of 30 Sep 2024627.13k2.57%
Schroder Investment Management North America, Inc.as of 30 Sep 2024593.85k2.43%
JPMorgan Investment Management, Inc.as of 30 Sep 2024586.56k2.40%
Geode Capital Management LLCas of 30 Sep 2024546.95k2.24%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.